Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Benzo(a)pyrene | 41 | 2022 | 126 | 10.270 |
Why?
|
| Colonic Neoplasms | 12 | 2021 | 186 | 4.750 |
Why?
|
| Fluorenes | 8 | 2013 | 26 | 2.470 |
Why?
|
| Carcinogens | 10 | 2016 | 124 | 2.210 |
Why?
|
| Environmental Pollutants | 10 | 2014 | 179 | 1.920 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 1371 | 1.510 |
Why?
|
| Liver | 10 | 2020 | 479 | 1.430 |
Why?
|
| Carcinogens, Environmental | 6 | 2018 | 35 | 1.370 |
Why?
|
| Endocrine Disruptors | 3 | 2023 | 39 | 1.270 |
Why?
|
| Ovary | 5 | 2022 | 108 | 1.250 |
Why?
|
| DNA Adducts | 6 | 2018 | 42 | 1.230 |
Why?
|
| Dietary Fats | 4 | 2013 | 119 | 1.130 |
Why?
|
| Biotransformation | 6 | 2018 | 67 | 1.090 |
Why?
|
| Education, Medical | 2 | 2023 | 104 | 1.000 |
Why?
|
| Animals | 47 | 2023 | 15081 | 0.950 |
Why?
|
| Gastrointestinal Tract | 3 | 2014 | 61 | 0.940 |
Why?
|
| Testis | 7 | 2022 | 187 | 0.840 |
Why?
|
| Saliva | 1 | 2023 | 107 | 0.820 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2022 | 421 | 0.810 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 11 | 0.730 |
Why?
|
| Rats, Inbred F344 | 16 | 2012 | 245 | 0.730 |
Why?
|
| Vascular Diseases | 1 | 2020 | 30 | 0.730 |
Why?
|
| Environmental Exposure | 4 | 2020 | 216 | 0.720 |
Why?
|
| Pressure | 1 | 2020 | 43 | 0.720 |
Why?
|
| Genes, APC | 3 | 2015 | 14 | 0.720 |
Why?
|
| Rats | 26 | 2016 | 3483 | 0.710 |
Why?
|
| Aorta | 4 | 2016 | 167 | 0.700 |
Why?
|
| Microsomes, Liver | 3 | 2016 | 70 | 0.680 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 142 | 0.670 |
Why?
|
| Subcellular Fractions | 3 | 2016 | 77 | 0.670 |
Why?
|
| Male | 35 | 2023 | 20025 | 0.650 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 260 | 0.650 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2015 | 17 | 0.640 |
Why?
|
| Air Pollutants | 5 | 2020 | 94 | 0.620 |
Why?
|
| Mice | 16 | 2022 | 5913 | 0.590 |
Why?
|
| Microsomes | 4 | 2010 | 52 | 0.530 |
Why?
|
| Humans | 30 | 2023 | 37093 | 0.520 |
Why?
|
| Body Burden | 1 | 2014 | 10 | 0.510 |
Why?
|
| Female | 28 | 2023 | 20969 | 0.490 |
Why?
|
| Colonic Polyps | 2 | 2012 | 67 | 0.480 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 251 | 0.470 |
Why?
|
| Administration, Oral | 8 | 2015 | 224 | 0.460 |
Why?
|
| Colon | 2 | 2013 | 103 | 0.440 |
Why?
|
| Risk Assessment | 4 | 2013 | 753 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 807 | 0.430 |
Why?
|
| Soil Pollutants | 1 | 2013 | 87 | 0.420 |
Why?
|
| Stilbenes | 1 | 2012 | 44 | 0.410 |
Why?
|
| Biological Availability | 7 | 2015 | 88 | 0.400 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 16 | 0.400 |
Why?
|
| Tissue Distribution | 7 | 2018 | 207 | 0.400 |
Why?
|
| Cytological Techniques | 1 | 2011 | 15 | 0.400 |
Why?
|
| Oxidative Stress | 2 | 2015 | 938 | 0.390 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2018 | 51 | 0.380 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 125 | 0.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2015 | 162 | 0.340 |
Why?
|
| Fertility | 2 | 2012 | 59 | 0.340 |
Why?
|
| Lung | 5 | 2012 | 446 | 0.340 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 4 | 2013 | 52 | 0.330 |
Why?
|
| Adipose Tissue | 1 | 2010 | 177 | 0.320 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2015 | 1039 | 0.320 |
Why?
|
| Students, Medical | 2 | 2021 | 130 | 0.320 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1198 | 0.310 |
Why?
|
| Behavior, Animal | 6 | 2015 | 314 | 0.310 |
Why?
|
| Fetus | 3 | 2015 | 105 | 0.290 |
Why?
|
| Anti-HIV Agents | 2 | 2021 | 420 | 0.280 |
Why?
|
| Spermatozoa | 1 | 2008 | 200 | 0.280 |
Why?
|
| Intestine, Small | 1 | 2005 | 25 | 0.270 |
Why?
|
| Diethylstilbestrol | 1 | 2004 | 6 | 0.250 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 19 | 0.250 |
Why?
|
| Prevalence | 2 | 2023 | 1455 | 0.250 |
Why?
|
| Fluorescence | 2 | 2020 | 121 | 0.240 |
Why?
|
| Catalase | 3 | 2016 | 109 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 2005 | 433 | 0.230 |
Why?
|
| Neurosecretory Systems | 1 | 2023 | 16 | 0.230 |
Why?
|
| Schools, Medical | 2 | 2023 | 198 | 0.230 |
Why?
|
| Buprenorphine | 1 | 2023 | 21 | 0.230 |
Why?
|
| Sheep | 3 | 2009 | 72 | 0.230 |
Why?
|
| Reproduction | 1 | 2023 | 71 | 0.220 |
Why?
|
| Apolipoproteins E | 2 | 2015 | 129 | 0.220 |
Why?
|
| Apoptosis | 3 | 2018 | 1398 | 0.220 |
Why?
|
| Estrogens | 2 | 2023 | 202 | 0.220 |
Why?
|
| Swine | 3 | 2009 | 184 | 0.220 |
Why?
|
| Microcephaly | 1 | 2022 | 19 | 0.210 |
Why?
|
| Mentors | 1 | 2023 | 127 | 0.210 |
Why?
|
| Gonads | 1 | 2022 | 20 | 0.210 |
Why?
|
| Melanoma | 1 | 2023 | 96 | 0.210 |
Why?
|
| Pregnancy, Animal | 1 | 2022 | 16 | 0.200 |
Why?
|
| Diet | 2 | 2005 | 801 | 0.200 |
Why?
|
| Cattle | 3 | 2009 | 477 | 0.200 |
Why?
|
| Pregnancy | 11 | 2022 | 1549 | 0.200 |
Why?
|
| Inhalation Exposure | 3 | 2011 | 43 | 0.200 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 159 | 0.200 |
Why?
|
| Community Health Services | 1 | 2023 | 185 | 0.190 |
Why?
|
| Placenta | 1 | 2022 | 97 | 0.190 |
Why?
|
| Cell Cycle | 2 | 2013 | 326 | 0.190 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 80 | 0.190 |
Why?
|
| Porosity | 1 | 2020 | 32 | 0.180 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2000 | 12 | 0.180 |
Why?
|
| Glutathione Transferase | 2 | 2018 | 88 | 0.180 |
Why?
|
| Solvents | 1 | 2020 | 99 | 0.180 |
Why?
|
| Bisexuality | 1 | 2023 | 208 | 0.180 |
Why?
|
| Stereoisomerism | 1 | 2020 | 167 | 0.180 |
Why?
|
| Students, Dental | 1 | 2019 | 4 | 0.180 |
Why?
|
| Particulate Matter | 1 | 2020 | 51 | 0.180 |
Why?
|
| Air Pollution | 1 | 2020 | 60 | 0.170 |
Why?
|
| Drug Interactions | 2 | 2013 | 141 | 0.170 |
Why?
|
| Organ Size | 3 | 2009 | 157 | 0.160 |
Why?
|
| Students, Nursing | 1 | 2019 | 39 | 0.160 |
Why?
|
| Time Factors | 4 | 2022 | 1742 | 0.160 |
Why?
|
| Brain | 5 | 2011 | 1346 | 0.160 |
Why?
|
| Physicians | 1 | 2021 | 163 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 286 | 0.160 |
Why?
|
| Social Environment | 1 | 2020 | 207 | 0.160 |
Why?
|
| Macrophages | 3 | 2022 | 439 | 0.160 |
Why?
|
| Prejudice | 1 | 2019 | 110 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 128 | 0.160 |
Why?
|
| DNA Damage | 1 | 2021 | 352 | 0.160 |
Why?
|
| Sexual Behavior | 1 | 2023 | 609 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2721 | 0.150 |
Why?
|
| Water | 1 | 2020 | 296 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 198 | 0.150 |
Why?
|
| Risk Factors | 2 | 2023 | 3562 | 0.150 |
Why?
|
| Mice, Knockout | 3 | 2015 | 933 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 1609 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2016 | 1518 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 502 | 0.150 |
Why?
|
| Body Weight | 3 | 2009 | 434 | 0.140 |
Why?
|
| HIV Infections | 2 | 2021 | 2303 | 0.140 |
Why?
|
| Cerebral Cortex | 3 | 2010 | 290 | 0.140 |
Why?
|
| Luteinizing Hormone | 4 | 2012 | 63 | 0.140 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 6 | 0.140 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2009 | 48 | 0.140 |
Why?
|
| Nystatin | 1 | 2016 | 6 | 0.140 |
Why?
|
| beta-Cyclodextrins | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cricetinae | 2 | 2007 | 238 | 0.130 |
Why?
|
| Eating | 2 | 2009 | 166 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 47 | 0.130 |
Why?
|
| Species Specificity | 2 | 2007 | 245 | 0.130 |
Why?
|
| Myometrium | 1 | 2015 | 13 | 0.130 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 40 | 0.130 |
Why?
|
| United States | 5 | 2023 | 4223 | 0.130 |
Why?
|
| Random Allocation | 3 | 2015 | 139 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 56 | 0.130 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 103 | 0.120 |
Why?
|
| Tennessee | 1 | 2014 | 70 | 0.120 |
Why?
|
| Antioxidants | 1 | 2018 | 416 | 0.120 |
Why?
|
| Discrimination Learning | 2 | 2011 | 28 | 0.120 |
Why?
|
| Animals, Newborn | 4 | 2004 | 343 | 0.120 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 37 | 0.120 |
Why?
|
| Administration, Inhalation | 5 | 2012 | 80 | 0.120 |
Why?
|
| Estrous Cycle | 2 | 2012 | 35 | 0.120 |
Why?
|
| Age Factors | 2 | 2014 | 1033 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 664 | 0.110 |
Why?
|
| HT29 Cells | 1 | 2013 | 45 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2016 | 308 | 0.110 |
Why?
|
| Meat | 1 | 2013 | 43 | 0.110 |
Why?
|
| Rats, Long-Evans | 5 | 2015 | 89 | 0.110 |
Why?
|
| Maternal Exposure | 2 | 2010 | 33 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2013 | 207 | 0.110 |
Why?
|
| Testosterone | 3 | 2008 | 193 | 0.100 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 9 | 0.100 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2011 | 9 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 172 | 0.100 |
Why?
|
| Chemical Fractionation | 1 | 2011 | 11 | 0.100 |
Why?
|
| Sonication | 1 | 2011 | 16 | 0.100 |
Why?
|
| Detergents | 1 | 2011 | 24 | 0.100 |
Why?
|
| Freeze Drying | 1 | 2011 | 27 | 0.100 |
Why?
|
| Solid Phase Extraction | 1 | 2011 | 13 | 0.100 |
Why?
|
| Superoxide Dismutase | 2 | 2009 | 155 | 0.100 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 197 | 0.100 |
Why?
|
| Infant | 1 | 2014 | 1046 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 65 | 0.100 |
Why?
|
| Sperm Motility | 2 | 2008 | 38 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 550 | 0.090 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2010 | 8 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2011 | 192 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 153 | 0.090 |
Why?
|
| Plasma | 1 | 2010 | 31 | 0.090 |
Why?
|
| Sex Factors | 2 | 2022 | 898 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 677 | 0.090 |
Why?
|
| Aerosols | 3 | 2011 | 48 | 0.090 |
Why?
|
| Middle Aged | 3 | 2020 | 10129 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 97 | 0.090 |
Why?
|
| Models, Animal | 1 | 2009 | 134 | 0.090 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2006 | 35 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 208 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 2379 | 0.080 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 24 | 0.080 |
Why?
|
| Neurons | 4 | 2011 | 1175 | 0.080 |
Why?
|
| Cod Liver Oil | 1 | 2008 | 1 | 0.080 |
Why?
|
| Absorption | 1 | 2008 | 25 | 0.080 |
Why?
|
| Plant Oils | 1 | 2008 | 18 | 0.080 |
Why?
|
| Half-Life | 1 | 2008 | 54 | 0.080 |
Why?
|
| Caprylates | 1 | 2008 | 11 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2008 | 88 | 0.080 |
Why?
|
| Solubility | 1 | 2008 | 118 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 138 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 237 | 0.080 |
Why?
|
| Receptors, Glutamate | 1 | 2007 | 27 | 0.070 |
Why?
|
| Mesocricetus | 1 | 2007 | 54 | 0.070 |
Why?
|
| Environment | 1 | 2008 | 138 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2007 | 129 | 0.070 |
Why?
|
| Jejunum | 1 | 2006 | 8 | 0.070 |
Why?
|
| Child | 1 | 2014 | 3131 | 0.070 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2006 | 9 | 0.070 |
Why?
|
| Particle Size | 2 | 2011 | 215 | 0.070 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2005 | 9 | 0.070 |
Why?
|
| Goats | 1 | 2005 | 19 | 0.070 |
Why?
|
| Haplorhini | 1 | 2005 | 22 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2010 | 1207 | 0.070 |
Why?
|
| Adult | 2 | 2014 | 11712 | 0.060 |
Why?
|
| Dogs | 1 | 2005 | 149 | 0.060 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2004 | 2 | 0.060 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2004 | 3 | 0.060 |
Why?
|
| Hematologic Tests | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2231 | 0.060 |
Why?
|
| Complex Mixtures | 1 | 2004 | 8 | 0.060 |
Why?
|
| Behavior | 1 | 2004 | 32 | 0.060 |
Why?
|
| Feces | 1 | 2004 | 111 | 0.060 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.060 |
Why?
|
| Epididymis | 1 | 2003 | 28 | 0.060 |
Why?
|
| Food Contamination | 1 | 2004 | 55 | 0.060 |
Why?
|
| Cerebellum | 2 | 2002 | 73 | 0.060 |
Why?
|
| Prostate | 1 | 2004 | 154 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2004 | 135 | 0.060 |
Why?
|
| SEER Program | 1 | 2023 | 91 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2011 | 137 | 0.050 |
Why?
|
| Naloxone | 1 | 2023 | 52 | 0.050 |
Why?
|
| Aged | 1 | 2014 | 6741 | 0.050 |
Why?
|
| Fetal Death | 1 | 2002 | 18 | 0.050 |
Why?
|
| Inflammation | 2 | 2022 | 618 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 1618 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 55 | 0.050 |
Why?
|
| Brazil | 1 | 2022 | 64 | 0.050 |
Why?
|
| Faculty | 1 | 2023 | 94 | 0.050 |
Why?
|
| Food Supply | 1 | 2004 | 112 | 0.050 |
Why?
|
| Keratins | 1 | 2022 | 25 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 174 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 441 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 337 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2000 | 444 | 0.050 |
Why?
|
| Genitalia, Male | 1 | 2001 | 13 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 617 | 0.050 |
Why?
|
| Lead | 2 | 1999 | 93 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 313 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 1492 | 0.050 |
Why?
|
| Phenotype | 2 | 2015 | 689 | 0.050 |
Why?
|
| Health Personnel | 1 | 2023 | 228 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2023 | 294 | 0.050 |
Why?
|
| Ornithine Decarboxylase | 1 | 1999 | 10 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2020 | 45 | 0.040 |
Why?
|
| Neocortex | 1 | 1999 | 27 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 257 | 0.040 |
Why?
|
| Lead Poisoning | 1 | 1999 | 26 | 0.040 |
Why?
|
| Reference Values | 1 | 2000 | 212 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2023 | 1369 | 0.040 |
Why?
|
| Computational Biology | 1 | 2022 | 293 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 922 | 0.040 |
Why?
|
| Spermine | 1 | 1999 | 64 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 120 | 0.040 |
Why?
|
| Litter Size | 2 | 2012 | 15 | 0.040 |
Why?
|
| Progesterone | 2 | 2012 | 113 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 562 | 0.040 |
Why?
|
| Students | 1 | 2023 | 519 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2026 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2010 | 435 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2016 | 11 | 0.040 |
Why?
|
| Peroxides | 1 | 2016 | 20 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 623 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 935 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2016 | 50 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2016 | 105 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 252 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 51 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 458 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 161 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 237 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 147 | 0.030 |
Why?
|
| Aging | 1 | 1999 | 664 | 0.030 |
Why?
|
| Premature Birth | 1 | 2015 | 75 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2020 | 642 | 0.030 |
Why?
|
| Ovulation | 1 | 2012 | 20 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2012 | 43 | 0.030 |
Why?
|
| Cyclophilin A | 1 | 2012 | 15 | 0.030 |
Why?
|
| Soot | 1 | 2011 | 4 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 602 | 0.020 |
Why?
|
| Motor Activity | 2 | 2006 | 418 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 90 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2012 | 97 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 8 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 262 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 128 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 75 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 37 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 431 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 356 | 0.020 |
Why?
|
| F2-Isoprostanes | 1 | 2009 | 20 | 0.020 |
Why?
|
| Furans | 1 | 2009 | 38 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 143 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 674 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2007 | 56 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 409 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2007 | 136 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 859 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 398 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 1908 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 513 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 111 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 140 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 893 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2003 | 24 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 29 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 65 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2004 | 102 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 136 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2003 | 87 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 62 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2002 | 32 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2002 | 76 | 0.010 |
Why?
|
| Staurosporine | 1 | 1999 | 38 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1999 | 93 | 0.010 |
Why?
|
| Neurotoxins | 1 | 1999 | 57 | 0.010 |
Why?
|